Covaxin: WHO wants ‘addl clarifications’
27.10.2021
The World Health Organisation’s technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech for its Covid-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for Emergency Use Listing of the vaccine. Hyderabadbased Bharat Biotech, which has developed Covaxin, had submitted EOI to the WHO on April 19 for the vaccine’s Emergency Use Listing (EUL). The TAG may get these clarifications by the end of this week, and aims to meet on November 3 for the final risk-benefit assessment.
No comments:
Post a Comment